Company Performance Metrics
BabyLiveAdvice is a revenue-generating digital health platform company that has built and validated two enterprise-grade, proprietary technology systems designed for scalable virtual care delivery and global healthcare education. With nine years of real-world development, operational deployment, and proven adoption, BabyLiveAdvice provides
healthcare organizations with ready-to-deploy infrastructure for both group-based engagement and high-volume clinical care across virtually any medical specialty or use case. At the core of the company are two highly scalable platforms: Enterprise Group Education & Class Platform with a full scale service from preconception to one year of age,
BabyLiveAdvice operates a robust, white-label-ready virtual group education system currently delivering more than 120 live classes per month, onboarding approximately 1,200 new users monthly, and serving over 7,000 unique parents annually. The platform supports fully branded hospital and enterprise deployments, self-managed patient portals, integrated payment collection, utilization analytics, and population-level reporting.
While proven in prenatal and postpartum education, the platform is use-case agnostic and expandable across healthcare markets, including pre-op and post-op education, diabetes and nutrition programs, behavioral health support groups, chronic disease management, and any scalable group-based clinical or educational model worldwide. The system is globally deployable and multilingual, supporting broad international adoption. BabyLiveAdvice has also developed its own fully proprietary telehealth infrastructure, including native mobile applications on both the Apple App Store and Android. Designed for enterprise-grade clinical scalability, the platform includes integrated EMR documentation, coding, AI-powered scribing, real-time translation across 250 languages, embedded payment tools, remote patient monitoring capabilities, and direct integration with AdvancedMD for insurance verification, billing, and claims. The platform is actively used in live operations, supporting 300–600 patient encounters per month, demonstrating clinical reliability, scalability, and broad applicability across urgent care, primary care, internal medicine, specialty care, behavioral health, and beyond—including nontraditional markets such as veterinary or hybrid care models. Together, these platforms represent a rare combination of proven technology, validated workflows, and revenue-generating deployment. BabyLiveAdvice’s systems can be licensed, white-labeled, or acquired by hospitals, payers, digital health companies, and international partners seeking scalable solutions without the cost, risk, or timeline of building from scratch. Unlike reimbursement-dependent telehealth startups, BabyLiveAdvice operates a resilient model funded through direct-to-consumer revenue and contracted hospital partnerships, reducing exposure to insurance volatility, legislative shifts, and payer-driven margin compression. This dual-channel structure creates predictable enterprise revenue with minimal regulatory fragility. BabyLiveAdvice is led by its founder and CEO, Sigi Marmorstein, a nationally recognized telehealth executive with over 20 years of healthcare leadership and more than 60 successful telehealth implementation projects across major health systems. Her expertise, credibility, and deep hospital relationships materially reduce execution risk and accelerate enterprise adoption, making BabyLiveAdvice not only a technology platform, but a trusted clinical partner positioned for scalable growth.
With proprietary infrastructure, validated utilization, global applicability, and a highly defensible business model, BabyLiveAdvice is uniquely positioned as a category-defining platform for the future of virtual care delivery and healthcare education.